Jordan

BMI View: We anticipated Jordanian pharmaceutical exports would increase in 2012 due to base effects around the Arab Spring in 2011. We project exports from Jordan will slow through... 2013-02-19

BMI View: Although Jordan's pharmaceutical market is not as attractive as those of Israel and Lebanon in the Gulf Levant, we are broadly positive on our outlook for the sector where... 2013-01-17

BMI View: We believe despite a temporary cash flow crisis for private hospitals in Jordan they will still have profited greatly from the influx of Libyan patients since the end of the... 2012-06-25

BMI View: We believe despite a temporary cash flow crisis for private hospitals in Jordan they will still have profited greatly from the influx of Libyan patients. It is our view that... 2012-03-22

BMI View: Though Jordan's pharmaceutical exports were poor in 2011, they should return to growth in 2012 as stability returns to the region and loose fiscal policy drives government... 2012-03-02

BMI Core View: Political stability, a cost-effective healthcare system and an established tourism sector are the fundamental prerequisites for developing a medical tourism industry.... 2012-02-09

BMI View: Despite the revenue restricting effects of the Arab Spring, the prospects of a second global recession and the Eurozone sovereign debt crisis, BMI believes Hikma Pharmaceuticals'... 2011-10-07